Risk factors leading to reduced bone mineral density in hemodialysis patients with metabolic syndrome

REFERENCES

• Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42:467–475.
   PubMed Web of Science ®Google Scholar
• Ersoy F. Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol. 2007;39:321–331.
   PubMed Web of Science ®Google Scholar
• Fournier A, Oprisiu R, Hottelart C, Renal osteodystrophy in dialysis patients: Diagnosis and treatment. Artif Organs. 1998;22:530–557.
   PubMedGoogle Scholar
• von Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Connor E. Associations between the metabolic syndrome and bone health in older men and women: The Rancho Bernardo study. Osteoporos Int. 2007;18:1337–1344.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• The IDF consensus worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf. Accessed August 12, 2005.
   Google Scholar
• Kanis JA, McCloskey EV. Evaluation of the risk of hip fracture. Bone. 1996;18(3 Suppl.):127S–132S.
   Google Scholar
• Kaji H, Suzuki M, Yano S, Risk factors for hip fracture in hemodialysis patients. Am J Nephrol. 2002;22:325–331.
   PubMedGoogle Scholar
• Foldes AJ, Arnon E, Popovtzer MM. Reduced speed of sound in tibial bone of hemodialysed patients: Association with serum PTH level. Nephrol Dial Transplant. 1996;11:1318–1321.
   PubMedGoogle Scholar
• Miller PD. Diagnosis and treatment of osteoporosis in chronic renal disease. Semin Nephrol. 2009;29:144–155.
   PubMed Web of Science ®Google Scholar
• Gerakis A, Hadjidakis D, Kokkinakis E, Apostolou T, Raptis S, Billis A. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol. 2000;13:437–443.
   PubMed Web of Science ®Google Scholar
• Lindergård B, Johnell O, Nilsson BE, Wiklund PE. Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment. Nephron. 1985;39:122–129.
   Google Scholar
• Miller PD. Treatment of osteoporosis in chronic kidney disease and end-stage renal disease. Curr Osteoporos Rep. 2005;3:5–12.
   PubMedGoogle Scholar
• Stein MS, Packham DK, Ebeling PR, Wark JD, Becker GJ. Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis. 1996;28:515–522.
   PubMed Web of Science ®Google Scholar
• Taal MW, Masud T, Green D, Cassidy MJ. Risk factors for reduced bone density in hemodialysis patients. Nephrol Dial Transplant. 1999;14:1922–1928.
   PubMed Web of Science ®Google Scholar
• Fletcher S, Jones RG, Rayner HC, Assessment of renal osteodystrophy in dialysis patients: Use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron. 1997;75:412–419.
   PubMed Web of Science ®Google Scholar
• Hutchison AJ, Whitehouse RW, Boulton HF, Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 1993;44:1071–1077.
   PubMed Web of Science ®Google Scholar
• Miller PD. The role of bone biopsy in patients with chronic renal failure. Clin J Am Soc Nephrol. 2008;3(Suppl. 3): S140–150.
   Google Scholar
• Brockstedt H, Christiansen P, Mosekilde L, Melsen F. Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. Bone. 1995;16: 109–117.
   PubMedGoogle Scholar
• Stehman-Breen CO, Sherrard DJ, Alem AM, Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int. 2000;58:2200–2205.
   PubMed Web of Science ®Google Scholar
• Nakashima A, Yorioka N, Tanji C, Bone mineral density may be related to atherosclerosis in hemodialysis patients. Osteoporos Int. 2003;14:369–373.
   PubMedGoogle Scholar
• Palmer SC, Strippoli GF, McGregor DO. Interventions for preventing bone disease in kidney transplant recipients: A systematic review of randomized controlled trials. Am J Kidney Dis. 2005;45:638–649.
   PubMed Web of Science ®Google Scholar
• Fletcher S, Jones RG, Rayner HC, Assessment of renal osteodystrophy in dialysis patients: Use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron. 1997;75: 412–419.
   PubMed Web of Science ®Google Scholar
• Rickers H, Christensen M, Rødbro P. Bone mineral content in patients on prolonged maintenance hemodialysis: A three year follow-up study. Clin Nephrol. 1983;20:302–307.
   PubMedGoogle Scholar
• Dawson-Hughes B, Shipp C, Sadowski L, Dallal G. Bone density of the radius, spine, and hip in relation to percent of ideal body weight in postmenopausal women. Calcif Tissue Int. 1987;40:310–314.
   PubMed Web of Science ®Google Scholar
• Kaji H, Hattori S, Sekita K, Sugimoto T, Chihara K. Factors affecting bone mineral density in hemodialysis patients with diabetic nephropathy. Endocr J. 2003;50:127–133.
   PubMedGoogle Scholar
• Cumming RG. Calcium intake and bone mass: A quantitative review of the evidence. Calcif Tissue Int. 1990;47:194–201.
   PubMed Web of Science ®Google Scholar